Immunomodulatory properties of stem cells from human exfoliated deciduous teeth

Stem Cell Research and Therapy

Volumn 1, Issue 1, 2010, Pages

  Yamaza, Takayoshi ^a,b   Kentaro, Akiyama ^a   Chen, Chider ^a   Liu, Yi ^a   Shi, Yufang ^c   Gronthos, Stan ^d   Wang, Songlin ^e   Shi, Songtao ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b KYUSHU UNIVERSITY   (Japan)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CD146 ANTIGEN; ENDOGLIN; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CHILD; CONTROLLED STUDY; EXFOLIATED DECIDUOUS TOOTH STEM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; OSTEOBLAST; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL TRANSPLANTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL; THERAPY EFFECT; TISSUE REGENERATION;

ADIPOGENESIS; ANIMALS; BONE MARROW CELLS; CELL PROLIFERATION; FEMALE; HETEROGRAFTS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE COUNT; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, NUDE; NEUROGENESIS; ODONTOGENESIS; OSTEOGENESIS; REGENERATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TELOMERASE; TH17 CELLS; TOOTH, DECIDUOUS;

MUS;

EID: 79251577049     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt5     Document Type: Article

References (40)

1. Marrow stromal cells as stem cells for nonhematopoietic tissues. Prockop DJ, Science 1997 276 71 74 10.1126/science.276.5309.71 9082988 (Pubitemid 27161245)
2. Bone marrow stromal stem cells: nature, biology, and potential applications. Bianco P Riminucci M, Gronthos S Robey PG, Stem Cells 2001 19 180 192 10.1634/stemcells.19-3-180 11359943 (Pubitemid 32524539)
3. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Friedenstein AJ Chailakhyan RK Latsinik NV Panasyuk AF, Keiliss-Borok IV,, Transplantation 1974 17 331 340 10.1097/00007890-197404000-00001 4150881
4. Stromal stem cells: marrow-derived osteogenic precursors. Owen M Friedenstein AJ, Ciba Found Symp 1988 136 42 60 3068016
5. Multilineage potential of adult human mesenchymal stem cells. Pittenger MF Mackay AM, Beck SC Jaiswal RK, Douglas R Mosca JD, Moorman MA Simonetti DW, Craig S Marshak DR, Science 1999 284 143 147 10.1126/science.284.5411.143 10102814 (Pubitemid 29282067)
6. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Bartholomew A Sturgeon C, Siatskas M Ferrer K, McIntosh K Patil S, Hardy W Devine S, Ucker D Deans R, Moseley A Hoffman R, Exp Hematol 2002 30 42 48 10.1016/S0301-472X(01)00769-X 11823036 (Pubitemid 34059216)
7. Mesenchymal stem cells: A new strategy for immunosuppression? Uccelli A Pistoia V Moretta L,, Trends Immunol 2007 28 219 226 10.1016/j.it.2007.03.001 17400510 (Pubitemid 46667240)
8. Human mesenchymal stem cells modulate B-cell functions. Corcione A Benvenuto F Ferretti E Giunti D, Cappiello V Cazzanti F, Risso M Gualandi F, Mancardi GL Pistoia V, Uccelli A,, Blood 2006 107 367 372 10.1182/blood-2005-07- 2657 16141348 (Pubitemid 43053565)
9. Mesenchymal stem cells stimulate antibody secretion in human B cells. Rasmusson I Le Blanc K, Sundberg B Ringdén O, Scand J Immunol 2007 65 336 343 10.1111/j.1365-3083.2007.01905.x 17386024 (Pubitemid 46481102)
10. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Ramasamy R Fazekasova H, Lam EW Soeiro I, Lombardi G Dazzi F, Transplantation 2007 83 71 76 10.1097/01.tp.0000244572.24780.54 17220794 (Pubitemid 46104974)
11. Mesenchymalstemcell-natural killer cell interactions: Evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Spaggiari GM Capobianco A Becchetti S Mingari MC, Moretta L,, Blood 2006 107 1484 1490 10.1182/blood-2005-07-2775 16239427 (Pubitemid 43242385)
12. Human mesenchymal stem cells modulate allogeneic immune cell responses. Aggarwal S Pittenger MF, Blood 2005 105 1815 1822 10.1182/blood-2004-04-1559 15494428
13. Developmental Committee of the European Group for Blood and Marrow Transplantation: Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Le Blanc K Frassoni F Ball L Locatelli F, Roelofs H Lewis I, Lanino E Sundberg B, Bernardo ME Remberger M, Dini G Egeler RM, Bacigalupo A Fibbe W, Ringdén O,, Lancet 2004 363 1439 1441 10.1016/S0140-6736(04)16104-7 15121408 (Pubitemid 38586721)
14. Mesenchymal stem cells in immunoregulation. Chen X Armstrong MA Li G,, Immunol Cell Biol 2006 84 413 421 10.1111/j.1440-1711.2006.01458.x 16869941 (Pubitemid 44286034)
15. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. Koç ON Gerson SL, Cooper BW Laughlin M, Meyerson H Kutteh L, Fox RM Szekely EM, Tainer N Lazarus HM, J Clin Oncol 2000 18 307 316 10637244 (Pubitemid 30056419)
16. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34 cells in NOD/SCID mice. Noort WA Kruisselbrink AB in't Anker PS Kruger M, van Bezooijen RL de Paus RA, Heemskerk MH Löwik CW, Falkenburg JH Willemze R, Fibbe WE,, Exp Hematol 2002 30 870 878 10.1016/S0301-472X(02) 00820-2 12160838 (Pubitemid 34838889)
17. Mesenchymal Stem Cell Transplantation Reverses Multi-Organ Dysfunction in Systemic Lupus Erythematosus Mice and Humans. Sun L Akiyama K Zhang H Yamaza T, Hou Y Zhao S, Xu T Le A, Shi S,, Stem Cells 2009 27 1421 1432 10.1002/stem.68 19489103
18. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Banas A Teratani T, Yamamoto Y Tokuhara M, Takeshita F Osaki M, Kawamata M Kato T, Okochi H Ochiya T, Stem Cells 2008 26 2705 2712 10.1634/stemcells.2008-0034 18535155
19. IFATS collection: Immunomodulatory effects of adipose tissue-derived stem cells in an allergic rhinitis mouse model. Cho KS Park HK Park HY Jung JS, Jeon SG Kim YK, Roh HJ,, Stem Cells 2009 27 259 265 10.1634/stemcells.2008-0283 18832595
20. Immunomodulatory properties of human periodontal ligament stem cells. Wada N Menicanin D Shi S Bartold PM, Gronthos S,, J Cell Physiol 2009 219 667 676 10.1002/jcp.21710 19160415
21. SHED: Stem cells from human exfoliated deciduous teeth. Miura M Gronthos S Zhao M Lu B, Fisher LW Robey PG, Shi S,, Proc Natl Acad Sci USA 2003 100 5807 5812 10.1073/pnas.0937635100 12716973 (Pubitemid 36576889)
22. An approachable human adult stem cell source for hard-tissue engineering. Laino G Graziano A, d'Aquino R Pirozzi G, Lanza V Valiante S, De Rosa A Naro F, Vivarelli E Papaccio G, J Cell Physiol 2006 206 693 701 10.1002/jcp.20526 16222704 (Pubitemid 43191044)
23. Stem cells from deciduous tooth repair mandibular defect in swine. Zheng Y Liu Y, Zhang CM Zhang HY, Li WH Shi S, Le AD Wang SL, J Dent Res 2009 88 249 254 10.1177/0022034509333804 19329459
24. SHED repair critical-size calvarial defects in immunocompromised mice. Seo BM Sonoyama W Coppe C Kikuiri T, Akiyama K Lee JS, Shi S,, Oral Diseases 2008 14 428 434 10.1111/j.1601-0825.2007.01396.x 18938268 (Pubitemid 351841717)
25. Mesenchymal Stem Cell-Mediated Ectopic Hematopoiesis Alleviates Aging-Related Phenotype in Immunocompromised Mice. Yamaza T Miura Y Akiyama K Bi Y, Sonoyama W Gronthos S, Chen W Le A, Shi S,, Blood 2009 113 2595 2604 10.1182/blood-2008-10-182246 19074727
26. Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Shi S Gronthos S Chen S Reddi A, Counter CM Robey PG, Wang CY,, Nat Biotechnol 2002 20 587 591 10.1038/nbt0602-587 12042862 (Pubitemid 34595152)
27. Post-natal dental pulp stem cells in vivo and in vitro. Gronthos S Mankani M Brahim J Robey PG, Shi S,, Proc Natl Acad Sci USA 2000 97 13625 13630 10.1073/pnas.240309797 11087820
28. Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents. Yamaza T Miura Y, Bi Y Liu Y, Akiyama K Sonoyama W, Patel V Gutkind S, Young M Gronthos S, Le A Wang CY, Chen W Shi S, PLoS ONE 2008 3 2615 10.1371/journal.pone.0002615 18612428
29. Periodontal ligament stem cell-mediated treatment for periodontitis in miniature swine. Liu Y Zheng Y Ding G Fang D, Zhang C Bartold PM, Gronthos S Shi S, Wang S,, Stem Cells 2008 26 1065 1073 10.1634/stemcells.2007-0734 18238856
30. T-regulatory cells in systemic lupus erythematosus. La Cava A, Lupus 2008 17 421 425 10.1177/0961203308090028 18490420 (Pubitemid 351798720)
31. IL-17 and the Th17 lineage in systemic lupus erythematosus. Garrett-Sinha LA John S Gaffen SL,, Curr Opin Rheumatol 2008 20 519 525 10.1097/BOR. 0b013e328304b6b5 18698171
32. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. Sato K Suematsu A, Okamoto K Yamaguchi A, Morishita Y Kadono Y, Tanaka S Kodama T, Akira S Iwakura Y, Cua DJ Takayanagi H, J Exp Med 2006 203 2673 2682 10.1084/jem.20061775 17088434 (Pubitemid 44833343)
33. Autoimmune disease: is it a disorder of the microenvironment? El-Badri NS Hakki A Ferrari A Shamekh R, Good RA,, Immunol Res 2008 41 79 86 10.1007/s12026-007-0053-8 18506645 (Pubitemid 351903814)
34. Novel therapies in lupus - focus on nephritis. Cordeiro AC Isenberg DA, Acta Reumatol Port 2008 33 157 169 18604181
35. Systemic Lupus Erythematosus. Rahman A Isenberg DA, N Engl J Med 2008 358 929 939 10.1056/NEJMra071297 18305268
36. Immune cells and cytokines in systemic lupus erythematosus: an update. Kyttaris VC Juang YT Tsokos GC,, Curr Opin Rheumatol 2005 17 518 522 10.1097/01.bor.0000170479.01451.ab 16093827 (Pubitemid 41527809)
37. Novel molecular targets in the treatment of systemic lupus erythematosus. Crispin JC Tsokos GC, Autoimmun Rev 2008 7 256 261 10.1016/j.autrev.2007.11.020 18190888
38. Targeting of the immune system in systemic lupus erythematosus. Ramanujam M Davidson A, Expert Rev Mol Med 2008 10 2 10.1017/S1462399408000562 18205972
39. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Neubert K Meister S Moser K Weisel F, Maseda D Amann K, Wiethe C Winkler TH, Kalden JR Manz RA, Voll RE,, Nat Med 2008 14 748 755 10.1038/nm1763 18542049 (Pubitemid 351951516)
40. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Mucida D Park Y, Kim G Turovskaya O, Scott I Kronenberg M, Cheroutre H, Science 2007 317 256 260 10.1126/science.1145697 17569825 (Pubitemid 47076203)